1564. Virological Suppression in People with HIV-1 (PWH) Receiving Dolutegravir/Lamivudine Was High and Similar across Age Groups despite Older PWH Having Increased Rates of Comorbidities and Polypharmacy (TANDEM Subgroup Analysis)

BACKGROUND: Aging with HIV has unique challenges, including comorbidities and drug-drug interactions. TANDEM was a retrospective medical chart review conducted across 24 US sites. This subgroup analysis examines stable-switch PWH receiving dolutegravir/lamivudine by age. METHODS: Eligible PWH were a...

Descripción completa

Detalles Bibliográficos
Autores principales: Brogan, Andrew P, Slim, Jihad, Verdier, Gustavo, Harper, Gavin, Mycock, Katie L, Wallis, Hannah, Donovan, Cynthia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678548/
http://dx.doi.org/10.1093/ofid/ofad500.1399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678548/
http://dx.doi.org/10.1093/ofid/ofad500.1399

Ejemplares similares